{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:51:26Z","timestamp":1785894686848,"version":"3.56.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":165,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Health Care Transitions"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.hctj.2026.100146","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:55:37Z","timestamp":1781913337000},"page":"100146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Transition and clinical outcomes among AYA with sickle cell disease"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9383-0894","authenticated-orcid":false,"given":"Chiamaka","family":"Nwachukwu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9904-039X","authenticated-orcid":false,"given":"Melody","family":"Benton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maissaa","family":"Janbain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9330-7940","authenticated-orcid":false,"given":"Madison","family":"Blackstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Farge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.hctj.2026.100146_bib1","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.hctj.2026.100146_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/hematology.2019000054","article-title":"A program of transition to adult care for sickle cell disease","volume":"2019","author":"Saulsberry","year":"2019","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.hctj.2026.100146_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27463","article-title":"Transition to adult care in sickle cell disease: a longitudinal study of clinical characteristics and disease severity","volume":"66","author":"Kayle","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"17","key":"10.1016\/j.hctj.2026.100146_bib4","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hctj.2026.100146_bib5","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/pbc.24557","article-title":"Sickle cell disease related mortality in the United States (1999-2009)","volume":"60","author":"Hamideh","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.hctj.2026.100146_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000930","article-title":"Burden of aging: health outcomes among adolescents and young adults with sickle cell disease","volume":"7","author":"Howell","year":"2023","journal-title":"Hemasphere"},{"issue":"5","key":"10.1016\/j.hctj.2026.100146_bib7","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.pedn.2015.06.008","article-title":"Measuring transition readiness: a correlational study of perceptions of parent and adolescents and young adults with sickle cell disease","volume":"30","author":"Speller-Brown","year":"2015","journal-title":"J Pediatr Nurs"},{"issue":"13","key":"10.1016\/j.hctj.2026.100146_bib8","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease","volume":"303","author":"Brousseau","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.hctj.2026.100146_bib9","article-title":"Exploring adult care experiences and barriers to transition in adult patients with sickle cell disease","volume":"1","author":"Bemrich-Stolz","year":"2015","journal-title":"Int J Hematol Ther"},{"issue":"3","key":"10.1016\/j.hctj.2026.100146_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265342","article-title":"Perspectives of individuals with sickle cell disease on barriers to care","volume":"17","author":"Phillips","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.hctj.2026.100146_bib11","unstructured":"Got Transition\u00ae. GotTransition.org. Accessed December 12, 2023. \u3008https:\/\/www.gottransition.org\/\u3009."},{"issue":"4","key":"10.1016\/j.hctj.2026.100146_bib12","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/S2352-3026(20)30036-3","article-title":"Paediatric to adult transition care for patients with sickle cell disease: a global perspective","volume":"7","author":"Inusa","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.hctj.2026.100146_bib13","unstructured":"Pediatric to adult hematologic care transition. Accessed December 12, 2023. \u3008https:\/\/www.hematology.org\/education\/clinicians\/clinical-priorities\/pediatric-to-adult-care-transition\u3009."},{"key":"10.1016\/j.hctj.2026.100146_bib14","unstructured":"Tulane doctors \u223c sickle cell center of Louisiana. Accessed January 22, 2024. \u3008https:\/\/medicine.tulane.edu\/tulane-doctors\/pediatrics\/pediatrics-centers-excellence\/sickle-cell-center-louisiana\u3009."},{"issue":"3","key":"10.1016\/j.hctj.2026.100146_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/MPH.0b013e3182847483","article-title":"Systematic review of transition from adolescent to adult care in patients with sickle cell disease","volume":"35","author":"Jordan","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"10.1016\/j.hctj.2026.100146_bib16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MPH.0b013e318211bb2e","article-title":"Growing up with sickle cell disease: a pilot study of a transition program for adolescents with sickle cell disease","volume":"33","author":"Smith","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.hctj.2026.100146_bib17","first-page":"250","article-title":"Applying a developmental\u2013ecological framework to sickle cell disease transition","volume":"1","author":"Griffin","year":"2013","journal-title":"Clin Pract Pediatr Psychol"},{"issue":"6","key":"10.1016\/j.hctj.2026.100146_bib18","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.pedhc.2012.06.004","article-title":"A transition pilot program for adolescents with sickle cell disease","volume":"26","author":"Hankins","year":"2012","journal-title":"J Pediatr Health Care"},{"issue":"3","key":"10.1016\/j.hctj.2026.100146_bib19","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1097\/DBP.0000000000001001","article-title":"The transition from pediatric to adult health care in young adults with Spina bifida: demographic and physician-related correlates","volume":"43","author":"Stiles-Shields","year":"2022","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"10.1016\/j.hctj.2026.100146_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1043659619896837","article-title":"Social and psychological factors associated with health care transition for young adults living with sickle cell disease","volume":"32","author":"Clayton-Jones","year":"2021","journal-title":"J Transcult Nurs"},{"issue":"8","key":"10.1016\/j.hctj.2026.100146_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/MPH.0000000000000427","article-title":"Transitioning adolescents and young adults with sickle cell disease from pediatric to adult health care: provider perspectives","volume":"37","author":"Stollon","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.hctj.2026.100146_bib22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/pbc.24870","article-title":"Identification of risk factors for an unsuccessful transition from pediatric to adult sickle cell disease care","volume":"61","author":"Andemariam","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.hctj.2026.100146_bib23","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/jpepsy\/jsx088","article-title":"Pediatric to adult care transition: Perspectives of young adults with sickle cell disease","volume":"42","author":"Porter","year":"2017","journal-title":"J Pediatr Psychol"},{"issue":"12","key":"10.1016\/j.hctj.2026.100146_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27939","article-title":"Correlates of successful transition in young adults with sickle cell disease","volume":"66","author":"Darbari","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"ement 1","key":"10.1016\/j.hctj.2026.100146_bib25","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1182\/blood-2022-169235","article-title":"Efficacy of interventions to build transition readiness for youth with sickle cell disease: a 13-year evaluation of a healthcare transition program","volume":"140","author":"Azul","year":"2022","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hctj.2026.100146_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jtct.2023.01.001","article-title":"Physical, mental, and social health of adult patients with sickle cell disease after allogeneic hematopoietic stem cell transplantation: a mixed-methods study","volume":"29","author":"Dovern","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"10","key":"10.1016\/j.hctj.2026.100146_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29209","article-title":"Transition care continuity promotes long-term retention in adult care among young adults with sickle cell disease","volume":"68","author":"Howell","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.hctj.2026.100146_bib29","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/pbc.24459","article-title":"Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs","volume":"60","author":"Blinder","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.hctj.2026.100146_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jemermed.2014.12.080","article-title":"Age-related emergency department reliance in patients with sickle cell disease","volume":"49","author":"Blinder","year":"2015","journal-title":"J Emerg Med"},{"issue":"5","key":"10.1016\/j.hctj.2026.100146_bib31","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/trf.13418","article-title":"High mortality among children with sickle cell anemia and overt stroke who discontinue blood transfusion after transition to an adult program","volume":"56","author":"McLaughlin","year":"2016","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.hctj.2026.100146_bib32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1017\/cts.2018.338","article-title":"Transition to adulthood and adult health care for patients with sickle cell disease or cystic fibrosis: current practices and research priorities","volume":"2","author":"Lanzkron","year":"2018","journal-title":"J Clin Transl Sci"},{"issue":"1","key":"10.1016\/j.hctj.2026.100146_bib33","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1002\/ajh.24953","article-title":"Pediatric to adult care co-location transitional model for youth with sickle cell disease","volume":"93","author":"Nolan","year":"2018","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hctj.2026.100146_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033535","article-title":"Value of an outpatient transition clinic for young people with inflammatory bowel disease: a mixed-methods evaluation","volume":"10","author":"Sattoe","year":"2020","journal-title":"BMJ Open"}],"container-title":["Health Care Transitions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294992322600019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294992322600019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:23:02Z","timestamp":1785892982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S294992322600019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":33,"alternative-id":["S294992322600019X"],"URL":"https:\/\/doi.org\/10.1016\/j.hctj.2026.100146","relation":{},"ISSN":["2949-9232"],"issn-type":[{"value":"2949-9232","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transition and clinical outcomes among AYA with sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Health Care Transitions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hctj.2026.100146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100146"}}